Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Cruciani, R. Rampazzo, M. Malena, L. Lazzarini, G. Todeschini, Andrea Messori, E. Concia (1996)
Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 23 4
S. Schimpff, V. Young, W. Greene, G. Vermeulen, M. Moody, P. Wiernik (1972)
Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.Annals of internal medicine, 77 5
C. Viscoli, E. Castagnola (2002)
Treatment of febrile neutropenia: what is new?Current Opinion in Infectious Diseases, 15
H. Wisplinghoff, H. Seifert, R. Wenzel, M. Edmond (2003)
Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 36 9
Walter Hughes, Donald Armstrong, G. Bodey, E. Bow, Arthur Brown, Thierry Calandra, Ronald Feld, Philip Pizzo, Kenneth Rolston, J. Shenep, Lowell Young (2002)
Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
T. Heikkinen, A. Järvinen (2003)
The common coldLancet (London, England), 361
C. Flowers, J. Seidenfeld, E. Bow, Clare Karten, C. Gleason, D. Hawley, N. Kuderer, A. Langston, K. Marr, K. Rolston, S. Ramsey (2013)
Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31 6
N. Kuderer, D. Dale, J. Crawford, L. Cosler, G. Lyman (2006)
Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patientsCancer, 106
T. Holland, V. Fowler, S. Shelburne (2014)
Invasive gram-positive bacterial infection in cancer patients.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 59 Suppl 5
A. Freifeld, E. Bow, K. Sepkowitz, M. Boeckh, J. Ito, C. Mullen, I. Raad, K. Rolston, Jo-Anne Young, J. Wingard (2011)
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 52 4
G. Lyman, E. Abella, R. Pettengell (2014)
Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review.Critical reviews in oncology/hematology, 90 3
C. Ellenbogen (1981)
The common cold.American family physician, 24 3
D. Kalman, S. Barriere (1991)
Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever.The Journal of infectious diseases, 163 1
IDSA GUIDELINES Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
G. Bodey, L. Jadeja, L. Elting (1985)
Pseudomonas bacteremia. Retrospective analysis of 410 episodes.Archives of internal medicine, 145 9
G. Kirkpatrick (1996)
THE COMMON COLDPrimary Care, 23
AG Freifeld, EJ Bow, KA Sepkowitz (2011)
Infectious Diseases Society of Americaa. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of AmericaClin Infect Dis, 52
S. Baum (2002)
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with CancerNEJM Journal Watch, 2002
N. Sipsas, G. Bodey, D. Kontoyiannis (2005)
Perspectives for the management of febrile neutropenic patients with cancer in the 21st centuryCancer, 103
P. Pizzo (1993)
Management of fever in patients with cancer and treatment-induced neutropenia.The New England journal of medicine, 328 18
original report memo (2019) 12:119–122 https://doi.org/10.1007/s12254-018-0468-z Investigation of seasonal frequency and pathogens in febrile neutropenia Seray Karagöz Özdemir · Utku Iltar · Ozan Salim · Orhan Kemal Yücel · Ramazan Erdem · Özge Turhan · Levent Undar Received: 8 October 2018 / Accepted: 18 December 2018 / Published online: 15 January 2019 © Springer-Verlag GmbH Austria, part of Springer Nature 2019 Summary 54.6% of FNEs. In 45.4% of 194 FNEs, pathogens were Background In patients with hematological malignan- isolated. Of all pathogens, 50.4% were gram negative cies, febrile neutropenia (FEN) is the most frequent bacteria, 29.2% were gram positive bacteria, 13.3% complication and the most important cause of mor- were viruses, 5.3% were fungi, and 1.8% were para- tality. Various risk factors have been identified for se- sites. vere infection in neutropenic patients. However, to Conclusıons The frequency of FEN does not change the best of our knowledge, it is not defined whether according to months or seasons. Also, the relative pro- there is a change in the risk of febrile neutropenia portions of different pathogens in the cause of FEN do according to seasons. The first aim of study was to not vary according to seasons. determine the
memo - Magazine of European Medical Oncology – Springer Journals
Published: Jan 15, 2019
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.